What is the appropriate sedation regimen for a 2‑ to 12‑month‑old infant weighing 3–8 kg undergoing MRI?

Sedation for MRI in 2-12 Month Old Infants (3-8 kg)

For infants aged 2-12 months undergoing MRI, oral chloral hydrate (50-75 mg/kg, up to 100 mg/kg) is the preferred first-line sedation agent, with IV pentobarbital (3-6 mg/kg) as an effective alternative when IV access is present or oral administration fails.

Primary Sedation Options

Oral Chloral Hydrate (First-Line for <18 months)

• Initial dose: 50-75 mg/kg orally
• Additional doses: 25-50 mg/kg as needed
• Maximum total dose: 100 mg/kg 1
• Success rate: >95% in infants <18 months 2
• Onset time: Approximately 18 minutes 3
• Advantages: Lower respiratory complication rate (0.2%) compared to IV pentobarbital 3

The evidence strongly supports chloral hydrate for this age group, with a large retrospective study of 6,006 children showing only 1% sedation failure rate and 0.06% requiring overnight hospitalization 1. Chloral hydrate is particularly appropriate for infants younger than 18 months, where success rates exceed 95% 2.

IV Pentobarbital (Alternative or Second-Line)

• Dosing protocol: Start with 2.5 mg/kg IV over 30 seconds
• Wait 1 minute, assess for disconjugate eye movements, yawning, or slowed respirations
• Additional doses: 1.25 mg/kg increments (wait 1 minute between doses)
• Total dose range: 3-6 mg/kg (average 3.75-4.5 mg/kg) 1
• Onset time: Approximately 6-7 minutes 1, 3
• Success rate: 97% for imaging completion 1

Pentobarbital shows higher respiratory depression rates (0.9% with oxygen desaturation) compared to oral chloral hydrate but remains highly effective 3. Recovery time is similar between routes at approximately 108 minutes 3.

Critical Safety Considerations for This Age Group

Special Monitoring Requirements for Neonates and Former Preterm Infants

The 2019 AAP guidelines emphasize that neonates and former preterm infants require specific management due to immature hepatic and renal function, which may prolong sedation and necessitate extended post-sedation monitoring 4. This is particularly relevant for the 2-12 month age range where many patients may be former preterm infants.

Required Monitoring (Per AAP Guidelines)

• Continuous: Pulse oximetry, heart rate, respiration
• Capnography: Required for deep sedation 4
• Documentation: Vital signs every 5 minutes during sedation
• Personnel: Practitioner skilled in airway management, bag-mask ventilation, intubation, and PALS immediately available 4

Adverse Events to Monitor

• Respiratory depression: Most common serious complication
• Transient oxygen desaturation (responds to repositioning in most cases)
• Vomiting (0.53% with chloral hydrate) 1
• Paradoxical hyperactivity (rare with pentobarbital in this age group) 1

Alternative Regimens (When Standard Options Fail or Contraindicated)

Propofol-Based Sedation

• Requires anesthesia-level expertise and continuous airway management capability
• Dosing: 1-2 mg/kg bolus followed by 5-5.4 mg/kg/h infusion 1
• Advantages: Faster recovery (19-24 minutes vs 35-40 minutes with pentobarbital) 1
• Disadvantages: Higher level of sedation, requires more intensive monitoring

Intranasal Dexmedetomidine + Buccal Midazolam

Recent evidence shows this non-parenteral combination achieves 95-97% success rates 5, 6:

• Dexmedetomidine: 1-3 μg/kg intranasal
• Midazolam: 0.2-0.5 mg/kg buccal
• Onset: 10 minutes median
• Advantage: No IV access required, good safety profile

Practical Algorithm

Step 1: Assess for IV access and procedure requirements

• No IV access needed: Start with oral chloral hydrate 50-75 mg/kg
• IV access present: Consider IV pentobarbital 2.5 mg/kg initial dose

Step 2: If initial sedation inadequate after appropriate onset time

• Chloral hydrate: Add 25-50 mg/kg (up to 100 mg/kg total)
• Pentobarbital: Add 1.25 mg/kg increments (up to 6 mg/kg total)

Step 3: If sedation fails with standard agents

• Consider intranasal dexmedetomidine + buccal midazolam
• Consult anesthesia for propofol-based sedation

Critical Pitfalls to Avoid

1. Avoid promethazine in children <2 years - FDA black box warning for fatal respiratory depression 4

2. Extended monitoring for long-acting agents - Pentobarbital and chloral hydrate require observation beyond standard recovery criteria, especially critical for infants in car seats where re-sedation can cause airway obstruction 4

3. Titration timing - Wait for full drug effect before additional dosing (chloral hydrate peaks later than pentobarbital) 4

4. Fasting status - Ensure appropriate NPO times per institutional protocols, though some evidence suggests oral chloral hydrate has been used successfully in non-fasted patients 1

5. Rescue capability - Must have skills to rescue from one level deeper than intended sedation depth, with age-appropriate airway equipment immediately available 4